Prediction of drug metabolism and interactions on the basis of in vitro investigations

被引:146
作者
Pelkonen, O
Turpeinen, M
Uusitalo, J
Rautio, A
Raunio, H
机构
[1] Univ Oulu, Dept Pharmacol & Toxicol, FIN-90014 Oulu, Finland
[2] Univ Kuopio, Dept Pharmacol & Toxicol, FIN-70211 Kuopio, Finland
[3] Univ Oulu, Dept Chem, FIN-90014 Oulu, Finland
关键词
D O I
10.1111/j.1742-7843.2005.pto960305.x
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Drug metabolism profoundly affects drug action, because almost all drugs are metabolised in the body and thus their concentrations and elimination rates are dependent on metabolic activity. Drug metabolism contributes substantially to interindividual differences in drug response and is also often involved in drug interactions, resulting in either therapeutic failure or adverse effects. Knowledge about the metabolism of a new chemical entity and its affinity to drug-metabolising enzymes helps in the drug development process by providing important information for the selection of a lead compound from among a number of substances pharmacologically equally effective in their therapeutic response. In drug development protocols, metabolism characteristics should be assessed very early during the development process. This has been made possible by the advances made especially in analytical capabilities and in in vitro technologies that are employed to predict in vivo metabolite profile, pharmacokinetic parameters and drug-drug interaction potential.
引用
收藏
页码:167 / 175
页数:9
相关论文
共 44 条
[1]
Andersson TB, 2001, DRUG METAB DISPOS, V29, P712
[2]
CULTURE OF PRECISION-CUT LIVER SLICES - EFFECT OF SOME PEROXISOME PROLIFERATORS [J].
BEAMAND, JA ;
PRICE, RJ ;
CUNNINGHAME, ME ;
LAKE, BG .
FOOD AND CHEMICAL TOXICOLOGY, 1993, 31 (02) :137-147
[3]
Boobis A.R., 1995, ADV DRUG METABOLISM, P513
[4]
BOOBIS AR, 1999, EUR S PRED DRUG MET
[5]
An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons [J].
Brandon, EFA ;
Raap, CD ;
Meijerman, I ;
Beijnen, JH ;
Schellens, JHM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 189 (03) :233-246
[6]
Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism -: Focus on in vitro studies [J].
Donato, MT ;
Castell, JV .
CLINICAL PHARMACOKINETICS, 2003, 42 (02) :153-178
[7]
Human hepatocytes as a tool for studying toxicity and drug metabolism [J].
Gómez-Lechón, MJ ;
Donato, MT ;
Castell, JV ;
Jover, R .
CURRENT DRUG METABOLISM, 2003, 4 (04) :292-312
[8]
Update information on human P450s [J].
Guengerich, FP .
DRUG METABOLISM REVIEWS, 2002, 34 (1-2) :7-15
[9]
Guillouzo A, 1995, ADV DRUG METABOLISM, P756
[10]
ECVAM's response to the changing political environment for alternatives: Consequences of the European Union chemicals and cosmetics policies [J].
Hartung, T ;
Bremer, S ;
Casati, S ;
Coecke, S ;
Corvi, R ;
Fortaner, S ;
Gribaldo, L ;
Halder, M ;
Roi, AJ ;
Prieto, P ;
Sabbioni, E ;
Worth, A ;
Zuang, V .
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2003, 31 (05) :473-481